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OPEN
ZIKAvirus elicits P53 activation and genotoxic stress in
human neural progenitors similar tomutations involved
in severe forms of genetic microcephaly and p53
Vincent El Ghouzzi1,10, Federico T Bianchi2,10, Ivan Molineris2,10, Bryan C Mounce3, Gaia E Berto2, Malgorzata Rak1, Sophie Lebon1,
Laetitia Aubry4, Chiara Tocco2, Marta Gai2, Alessandra MA Chiotto2, Francesco Sgrò2, Gianmarco Pallavicini2,
Etienne Simon-Loriere5,6, Sandrine Passemard1,7, Marco Vignuzzi3, Pierre Gressens*,1,8 and Ferdinando Di Cunto*,2,9
Epidemiological evidence from the current outbreak of Zika virus (ZIKV) and recent studies in animal models indicate a strong
causal link between ZIKV and microcephaly. ZIKV infection induces cell-cycle arrest and apoptosis in proliferating neural
progenitors. However, the mechanisms leading to these phenotypes are still largely obscure. In this report, we explored the
possible similarities between transcriptional responses induced by ZIKV in human neural progenitors and those elicited by three
different genetic mutations leading to severe forms of microcephaly in mice. We found that the strongest similarity between all
these conditions is the activation of common P53 downstream genes. In agreement with these observations, we report that ZIKV
infection increases total P53 levels and nuclear accumulation, as well as P53 Ser15 phosphorylation, correlated with genotoxic
stress and apoptosis induction. Interestingly, increased P53 activation and apoptosis are induced not only in cells expressing high
levels of viral antigens but also in cells showing low or undetectable levels of the same proteins. These results indicate that P53
activation is an early and specific event in ZIKV-infected cells, which could result from cell-autonomous and/or non-cell-
autonomous mechanisms. Moreover, we highlight a small group of P53 effector proteins that could act as critical mediators, not
only in ZIKV-induced microcephaly but also in many genetic microcephaly syndromes.
Cell Death and Disease (2016) 7, e2440; doi:10.1038/cddis.2016.266; published online 27 October 2016
The achievement of normal brain size and structure during
development requires the generation and survival of an
appropriate number of neurons. Genetic and environmental
conditions that affect the normal expansion of neuronal
progenitors, the timing of their differentiation and the survival
of their progeny may severely reduce the final number of brain
cells, resulting inmicrocephaly. Congenital microcephaly (CM)
is a heterogeneous group of disorders characterized by
reduced head circumference at birth, to at least 3 S.D. below
the mean.1–6 Although CM can be an isolated abnormality,
compatible with normal intelligence, it often becomes clinically
relevant because of its association with invalidating comorbid-
ities such as severe intellectual disability, cerebral palsy,
epilepsy or other syndromic features.6 CM can be the result of
rare genetic disorders, mostly characterized by autosomal
recessive inheritance.4,7 Even more frequently, CM is pro-
duced by environmental factors such as hypoxia, drugs and
alcohol exposure, or infectious agents such as Rubella,
Toxoplasmosis or cytomegalovirus (CMV).6 Zika virus (ZIKV),
a mosquito-borne flavivirus originally identified in Uganda
in 1947,8 is the latest addition to the list of infectious agents
that may lead to microcephaly. Since 2015, the spreading of
ZIKV infection in Brazil and throughout Latin America has
been associated with a sharp increase of the incidence of
severe CM,8–10 leading to the declaration of a 'Global
Emergency' by the World Health Organization. The possibility
of vertical transmission from mother to fetus was first
supported by detection of ZIKV in the amniotic fluid of two
pregnant women whose fetuses had been diagnosed with
microcephaly.11 ZIKV was then found in microcephalic fetal
brain tissue, together with multifocal dystrophic lesions in the
cortex and subcortical white matter.9 ZIKV efficiently infects
human neural progenitors cells derived from induced plur-
ipotent stem cells or from embryonic stem (ES) cells, reducing
their proliferation and causing their death, as it has first been
shown in 2D cultures12 and then in human brain
organoids.13–15 Recently, studies in mouse models have
demonstrated that infection of developing mouse brain by
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direct injection16 or by vertical transmission from the
mother17–19 severely affects brain growth. Although the causal
link between ZIKV infection and microcephaly is firmly
established, it is still not clear why the developing brain is
specifically vulnerable. ZIKV can infect different cell types,
such as skin keratinocytes, fibroblasts and dendritic cells.20,21
Viral entry can take place through different receptors,
including DC-SIGN, Tyro3, TIM-1 and especially AXL.20 High
levels of AXL are also expressed in the developing human
cortex by radial glial cells, astrocytes, endothelial cells and
microglia,22 providing a possible explanation of how ZIKV
could reach the proliferating neural precursors. The cytopathic
effect of ZIKV in infected skin cell is characterized by
increased autophagosome formation, vacuolation and strong
interferon response.20 Accordingly, over 80% of postnatal
ZIKV cases are asymptomatic, whereas the remaining cases
only exhibit mild fever, cutaneous rash and joint pain for a
period of 7 days.10,12–14,20 In contrast, cultured neuronal
progenitors12–15 and developing human9 and mouse17–19
brains infected by ZIKV display massive alterations, with
prominent apoptotic cell death. In ZIKV-infected organoids,
many apoptotic cells are not immunostained by antibodies
directed to viral antigens,15 suggesting the involvement of non-
cell-autonomous mechanisms. ZIKV induces TLR3 over-
expression in human neurospheres and organoids, and
TLR3-competitive inhibitor attenuated organoid shrinkage.13
Nevertheless, the mechanisms of cell-cycle dysregulation and
apoptosis induction by ZIKV in neural progenitors are still
largely obscure. A distinct possibility to explain the specificity
of these phenotypes is that ZIKV infection may directly or
indirectly affect some of the molecular mechanisms that are
also implicated in the pathogenesis of genetic CM.4,7,23 In this
report, we explored this possibility, by comparing the gene
expression profile of induced pluripotent stem cell (iPSC)-
derived human neural progenitors cells (hNPCs) infected with
ZIKV,12 with the profiles of developing neural tissues obtained
from three different mouse models of severe genetic micro-
cephaly. We found that P53 activation is a likely convergence
point between the analyzed genetic models and ZIKV-infected
cells. Therefore, we set out to experimentally test whether this
event actually occurs and how it may be connected to
apoptosis and genotoxic stress. The results of these experi-
ments are described and discussed.
Results
Comparison of gene expression profiles between ZIKV-
infected neural progenitors and mouse models of genetic
microcephaly. Previous analysis of gene expression by
RNA-sequencing (RNA-seq) of iPSC-derived hNPCs revea-
led that ZIKV infection significantly alters the expression
of thousands genes.12 Among the downregulated genes,
a strong prevalence of cell-cycle-related pathways was
observed, which together with FACS analysis indicated that
ZIKV arrests cell proliferation.12 On the other hand, Gene
Ontology (GO) analysis of upregulated genes displayed
enrichment of proteins involved in transcription, protein
transport and catabolic processes, together with increased
expression levels of genes involved in the regulation of
apoptosis.12 However, considering the very high number of
genes modulated by ZIKV infection (3434 upregulated and
3414 downregulated genes; Supplementary Table S1), it is
difficult to understand which alterations could be causally
linked to ZIKV-induced microcephaly and which may only
represent bystander effects. To address whether the mole-
cular events induced by ZIKV infection display significant
similarities with genetic microcephaly, we set out to compare
the expression profiles of ZIKV-infected hNPCs12 with the
profiles of developing neural tissues obtained from three
different mouse models of severe genetic microcephaly, that
is, CitK− /− mice,24 Magoh+/− mice25 and conditional Elp3-
knockout mice.26 CitK is a ubiquitous protein implicated
in midbody maturation,27–29 whose inactivation leads to
cytokinesis failure and massive apoptosis in the mammalian
developing brain.24,30 We obtained RNA-seq data from
control and CitK− /− developing cerebellum (Bianchi et al.,
Gene Expression Omnibus data set no. GSE83465), which is
the neural tissue more severely affected by CitK loss.24
Magoh protein is one of the core components of the
exon junction complex, implicated in nonsense-mediated
decay pathway.31 Magoh haploinsufficiency leads to micro-
cephaly,25 through prolonged mitosis of cortical neural
progenitors, accumulation of DNA damage, premature
differentiation and P53-dependent apoptosis.25,32
Elp3 is a catalytic histone acetyltransferase subunit of the
RNA polymerase II elongator complex,33 which has been
associated with transcriptional elongation and with specific
modification of uridines at the wobble base position of
tRNAs.34 Deletion of Elp3 results in impaired codon translation
speed and triggers unfolded protein response (UPR), via
activation of the PERK-eIF2α-Atf4 signaling.26 Conditional
deletion of Elp3 in developing mouse brain leads to
microcephaly, due to impairment of indirect neurogenesis,
but not due to apoptosis.26 Gene expression profiles of E10.5
cortices obtained from Magoh+/− embryos and of E14.5
brains obtained from Elp3 conditional knockout mice were
publicly available in the Gene Expression Omnibus (with
accession numbersGSE19168 andGSE74683, respectively).
In all these data sets, the number of significantly modulated
genes is much lower compared with that in the ZIKV data
set (Supplementary Table S1). Specifically, modulated genes
were 370 in the CitK− /− study (199 upregulated and 171
downregulated), 119 in the Magoh+/− study (50 upregulated
and 69 downregulated) and 413 in the Elp3 study (256
upregulated and 157 downregulated). Comparison of the
genes in these lists (Figure 1) revealed a strong similarity
between CitK and Magoh data sets, with 14 common
upregulated genes (P= 3.9E−17) and 9 common down-
regulated genes (P=6.9E− 09). In addition, both data sets
displayed a lower but statistically significant intersection with
the Elp3 data set (Figure 1,P-value=3.1E− 03 and 3.9E− 04,
respectively).
Considering also that CitK and Magoh data sets have
been obtained on two different developing neural tissues
(P4 cerebellum versus E10.5 cortex, respectively) and with
two different gene expression analysis technologies (RNA-
seq and DNA microarrays, respectively), these results are
consistent with the higher phenotypical similarity between
these two models of microcephaly, if compared with
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microcephaly resulting from conditional Elp3 deletion. Thus,
the 14 upregulated genes and the 9 downregulated genes
common to the CitK and to the Magoh data sets
(Supplementary Table S2) are likely to have crucial roles in
apoptotic microcephaly. Interestingly, 11 of the 14 common
upregulated genes are P53 targets, and most of them have
been involved in P53-dependent apoptosis and/or cell-cycle
arrest (Supplementary Table S2). This result is consistent with
the fact that both CitK− /− and Magoh+/− developing neural
tissues display apoptosis.24,32 Conversely, five of the nine
common downregulated genes are well-known developmental
regulators of the CNS (Supplementary Table S3). Notably,
these genes include the transcription factor EOMES (TBR2),
which is one of the most established markers for committed
neural progenitors35 and may regulate the progression from
neural stem cell to intermediate progenitors.36 Next, we
compared the genes modulated in each microcephaly model
with the genes showing altered expression in ZIKV-infected
neural stem cells (Figure 1). CitK- and Magoh-upregulated
genes showed a small but statistically significant overlap
with ZIKV-upregulated genes (21 and 16 genes, P-values=
2.7E−03 and 8E− 04, respectively). Despite the limited
overlap, six genes, corresponding to well-known targets
of P53, were common to the three lists (expected 0.08
Po1E−10, χ2 test). Similarly, six genes were common to the
corresponding lists of downregulated genes (expected 0.07
Po1E−10, χ2 test).
ZIKV-upregulated genes overlapped with Elp3-upregulated
genes even more than with CitK- and Magoh-upregulated
sequences (107 common genes P=9.5E− 21; Supplemen-
tary Table S4), whereas the overlap between downregulated
genes was not statistically significant. These common genes
were enriched of aminoacyl-tRNA synthases (7E−8) by GO
analysis.37,38 Moreover, Gene Set Enrichment analysis
(GSEA)39,40 in the Molecular Signature Database (http://
software.broadinstitute.org/gsea) revealed a strong overlap
with genes upregulated in unfolded protein response (UPR)
(set M5922, P=2.29E−9). Interestingly, ZIKV- and Elp3-
upregulated genes include the P53 targets AEN, CCNG1,
EDA2R andPHLDA3, which are sharedwith CitK- andMagoh-
upregulated genes (Supplementary Table S2). Altogether,
these observations indicate that ZIKV-infected cells and at
least three independent mouse models of genetic microce-
phaly share the activation of P53-target genes.
A signature of P53 activation is common to Zika and
microcephaly models. To explore more, in general, the
extent of P53 pathway activation in ZIKV-infected neural
progenitors and in the analyzed microcephaly models, we
resorted to GSEA, a powerful analytical method for
interpreting gene expression data that focuses on specific
gene sets obtained in different and heterogeneous studies.40
In particular, we concentrated our analysis on 50 gene
expression signatures related to P53 function and evaluated
their overlap with the lists of upregulated in the ZIKV, CitK,
Magoh and Elp3 data sets. Strikingly, 32 of these data sets
showed statistically significant overlap with ZIKV-upregulated
genes (Table 1). As expected, a highly significant overlap
was observed also with the CitK- and Magoh-upregulated
genes, but the number of significant sets was lower
compared with the ZIKV-upregulated genes (19 and 13 sets,
respectively; Table 1). Interestingly, even Elp3-upregulated
genes overlapped with many P53-related data sets (Table 1),
further suggesting that P53 is activated in Elp3-deficient
cortex (14 sets; Table 1). To evaluate whether P53
pathway activation is a specific feature of ZIKV-infected
neural cells, rather than a nonspecific consequence of viral
burden and highly deregulated transcriptome, we analyzed
by GSEA the overlap between P53-related sets and genes
upregulated in hNPCs after infection with the unrelated
microcephaly virus CMV (Luo et al.,41 GEO accession
number GSE19345). Strikingly, in this case only two sets
showed significant overlap, and with relatively high P-values
(Table 1). In addition, the overlap between genes upregulated
by ZIKV and CMV was not significant. In contrast, we
found a significant overlap between genes upregulated by
Figure 1 Comparison of gene expression profiles obtained from ZIKV-infected hNPCs and from mouse models of severe microcephaly. (a) Graphical representation of
intersections between genes upregulated in ZIKV-infected hNPCs (ZIKV), CitK− /− P4 cerebellum (CitK), Magoh+/− E10.5 neocortex (Magoh) and Elp3− /− E13.5 brain
(Elp3). The corresponding gene lists are reported in Supplementary Table S1. (b) Graphical representation of intersections between genes downregulated in the same conditions.
Venn diagrams were obtained using the web tool http://bioinformatics.psb.ugent.be/webtools/Venn/
ZIKV-induced microcephaly and p53
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CMV and downregulated by ZIKV (64 genes, P=6.10E− 04;
Supplementary Table S5). This group included many
genes involved in cell-cycle control (Supplementary Table
S5; P= 4.1E−5), such as E2F1 and many of its targets. In
conclusion, the above analysis of gene expression
profiles revealed that, similarly to three microcephalic
mutations, but differently from CMV, ZIKV activates in
hNPCs an antiproliferative and proapoptotic P53-related
response.
P53 is activated in ZIKV-infected cells. The above data
strongly suggest that P53 is activated by ZIKV infection, an
event that could be critical for proliferative block and
apoptosis induction. To validate this prediction, we performed
P53 immunodetection in human NSCi90 hNPCs, under
control conditions or after infection with the French Poly-
nesian variant of ZIKV, which has been associated with
microcephaly.42,43 Increased nuclear accumulation of P53 is
known to correlate with P53 activation.44,45 ZIKV infection
significantly enhanced the number of cells with P53-positive
nuclei (Figures 2a and b), as well as the average nuclear
P53 intensity (Figure 2b). Interestingly, counterstaining
with antibodies directed against flavivirus proteins (4G2) did
not show a good correlation between accumulation of viral
antigens and P53 nuclear positivity (Figures 2a and c).
Indeed, in the infected samples, the distribution of P53
nuclear intensity was essentially the same in 4G2-positive
and -negative cells (Figure 2c). In agreement with the
immunofluorescence results, western blotting analysis
revealed a robust increase of P53 total protein levels, both
24 and 48 h after infection (Figure 2d). Moreover, blotting of
the same protein extracts with antiphospho-Ser15 P53
antibodies revealed that this post-translational modification,
an established marker of P53 functional activation,46 is
significantly increased at 48 h (Figure 2d). To evaluate
whether increased P53 levels and nuclear accumulation
induced by ZIKV are accompanied by P53 functional
activation, we analyzed by qPCR mRNA levels of five of the
P53 targets reported in Supplementary Table S2. As
expected, the expression of AEN, CDKN1A and PHLDA3
was significantly increased in the infected cells, whereas
no differences were detected for EDA2R and CCNG1.
Conversely, the expression of CDKN1C was significantly
downregulated in the infected cells (Figure 2e), further
validating our bioinformatic analysis.
Table 1 Genes upregulated in ZIKV-infected hNPCs and in mouse models of severe microcephaly significantly overlap with P53-related data sets
MSigDB se Zika CMV CitK− /− Magoh+/− Elp3− /−
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53 2.36E−06
AMUNDSON_DNA_DAMAGE_RESPONSE_TP53 1.16E−06 2.95E−06 5.58E−06 5.57E−04
BIOCARTA_P53_PATHWAY 1.20E−03 6.20E−03 8.57E−04
BIOCARTA_P53HYPOXIA_PATHWAY 1.50E−03 1.44E−03
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A 1.00E−35 5.29E−07 2.69E−04
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B 5.65E−26 3.33E− 03 9.11E−05 1.90E−04 1.23E−03
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C 7.90E−03
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D 3.16E−13
CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP 9.92E−04
HALLMARK_P53_PATHWAY 6.25E−34 1.45E−15 1.71E−16 1.62E−04
INGA_TP53_TARGETS 2.45E−04 3.49E−06 3.64E−08
KANNAN_TP53_TARGETS_DN 9.50E−03
KANNAN_TP53_TARGETS_UP 5.37E−08 6.10E−03 1.35E−03
KEGG_P53_SIGNALING_PATHWAY 7.91E−09 8.69E−09 2.15E−13
MARTINEZ_RB1_AND_TP53_TARGETS_DN 1.48E−26 5.89E−08 8.07E−09
MARTINEZ_RB1_AND_TP53_TARGETS_UP 4.21E−21 2.07E−06
MARTINEZ_TP53_TARGETS_DN 5.70E−26 7.78E−06 1.78E−07
MARTINEZ_TP53_TARGETS_UP 6.53E−23 1.27E−08
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN 1.47E−03
ONGUSAHA_TP53_TARGETS 6.43E−07 1.94E−14 5.42E−11
P53_DN.V1_DN 2.76E−04 1.05E−06 4.83E−03 2.73E−03
P53_DN.V1_UP 2.38E−10 2.44E−05
P53_DN.V2_DN 1.21E−03 1.28E−05
PEREZ_TP53_AND_TP63_TARGETS 7.06E−18 1.60E−04
PEREZ_TP53_TARGETS 1.59E−50 7.54E− 03 4.75E−04 1.17E−03
PID_P53_DOWNSTREAM_PATHWAY 5.42E−11 3.99E−10 4.07E−06 3.59E−03
PID_P53_REGULATION_PATHWAY 4.17E−11
REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE 1.18E−03
SCHAVOLT_TARGETS_OF_TP53_AND_TP63 1.63E−04 5.86E−03 7.62E−04
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN 3.25E−07
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP 6.50E−07
TANG_SENESCENCE_TP53_TARGETS_UP 2.70E−03
V$P53_02 4.24E−22 9.72E−03 9.11E−03
V$P53_DECAMER_Q2 2.59E−13
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 1.71E−04
Abbreviations: CMV, cytomegalovirus; GSEA, gene set enrichment analysis; hNPC, human neural progenitors cell; MSigDB, Molecular Signature Database; ZIKV,
Zika virus
The table reports the significant (Po0.01) corrected P-values for the overlaps between the indicated GSEA data sets and the genes upregulated in ZIKV-infected
hNPCs (ZIKV), CMV-infected hNPCs, CitK− /− P4 cerebellum, Magoh+/− E10.5 neocortex and Elp3− /− E13.5 brain. The corresponding gene lists are reported in
Supplementary Table S1
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Apoptosis and genotoxic stress in ZIKV-infected cells. In
agreement with previous reports, ZIKV-infected hNSC cul-
tures displayed increased rate of apoptotic cells, as revealed
by analysis of pyknotic nuclei (not shown) and by immuno-
staining with antibodies directed to activated caspase-3
(Figures 3a and b). Even in this case, no correlation was
evident between apoptosis and viral cellular load in infected
cultures, as ~ 60% of caspase-3-positive cells were negative
for 4G2 antibody staining (Figure 3b). Most caspase-3-
positive cells in ZIKV-infected cultures displayed increased
levels of phospho-Ser15 P53 immunoreactivity, an estab-
lished marker of active P53,46 which was especially
concentrated in the nucleus (Figure 3c). Accordingly, western
blotting analysis revealed increased caspase-3 levels
(Figure 3d).
Many different viruses, including flaviviruses, are known to
induce genotoxic stress in infected cells,47,48 which is one of
the main stimuli leading to P53 activation. Therefore, we
assessed whether ZIKV-infected cells display increased DNA
damage. To do so, we quantified nuclear foci of phosphory-
lated H2Ax histone (γH2Ax), a well-establishedmarker of DNA
double-strand breaks.49 In comparison with other normal cell
types, NSCi90 hNPCs cells display a relatively high average
number of γH2Ax foci already under basal conditions,
consistent with the idea that neural progenitors may be
particularly susceptible to replicative stress.50 Interestingly,
Figure 2 Increased P53 activation in ZIKV-infected hNPCs. (a) Control (CTRL) and infected (ZIKV) NSCi90 cells were analyzed 48 h after infection by immunofluorescence
with anti-total P53 (P53) and anti-flavivirus antigens (4G2), and counterstained with DAPI (4',6-diamidino-2-phenylindole). The figure shows a representative high magnification
field. Note the low or absent 4G2 signal in many of the infected cells showing strong P53 nuclear positivity. (b) Quantification of P53 nuclear intensity in arbitrary units (a.u.) in cells
imaged in the above experiment (n= 600 for each condition). (c) Distribution of P53 nuclear intensity in non-infected cells (CTRL) and in infected cells showing undetectable
(ZIKV-4G2-Neg.) or detectable (ZIKV-4G2-Pos.) levels of flavivirus antigens. Quantifications in (b) and (c) are representative of three independent infections. Scale bar= 10 μm.
(d) Total cell extracts of control cells and of cells infected with ZIKV for 24 or 48 h were analyzed by western blotting with the indicated antibodies. Actin, internal loading control;
C-caspase, cleaved caspase. (e) Control or ZIKV-infected cells were analyzed by qRT-PCR for the indicated genes. GOI, gene of interest. Error bars, S.E.M. ***Po0.001;
*Po0.05. Statistical significance was assessed by two-tailed unpaired Student's t-test in panels (c and d) and two-tailed Mann–Whitney U-test in panel (e)
ZIKV-induced microcephaly and p53
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24 h after infection, ZIKV-infected cells displayed a significant
increase in the average number of foci/nucleus, regardless
of whether they showed detectable viral antigens or not
(Figures 3d and e). However, the number of foci was
consistently higher if only cells with visible 4G2 signal were
considered (Figures 3d and e).
Altogether, our results demonstrate that cultures of hNPCs
infected by ZIKV are characterized by genotoxic stress, P53
activation and apoptotic cell death and that the latter two
events are not well correlated with the levels of 4G2 viral
antigens.
Discussion
In this report, we have provided bioinformatic evidence that
transcriptional activation of P53 downstream effectors is the
most consistent common molecular feature shared by ZIKV-
infected hNPCs and by three different mouse models of
microcephaly. Moreover andmost importantly, we have shown
that P53 is specifically activated by ZIKV infection in hNPCs.
Previous studies in rodent models found that P53-induced
apoptosis is responsible for neuronal loss in many different
congenital microcephalies.32,51–55 In some of these cases,
P53 activation was correlated with increased DNA damage
Figure 3 Increased P53 activation in ZIKV-infected hNPCs. (a) Control (CTRL) and infected (ZIKV) NSCi90 cells were analyzed 48 h after infection by immunofluorescence
with anti-tubulin, anti-cleaved caspase-3 (C-cas 3) and anti-flavivirus antigens (4G2), and counterstained with DAPI (4',6-diamidino-2-phenylindole). The field shown in figure
contains a caspase-positive/4G2-intense cell (yellow arrowhead in the merge), a caspase-positive cell with low 4G2 signal (green arrowhead) and a caspase-negative/4G2-
positive cell (red arrowhead). Scale bar= 5 μm. (b) The first two bars of the histogram represent a quantification of the average frequency of caspase-3-positive cells in control
and infected cells. The third bar represents the relative levels of 4G2-positive (red) and 4G2-negative (white) cells in caspase-3 positive cells of the infected samples. Error
bars= S.E.M. (n= 4000). (c) Representative image of ZIKV-infected cells stained with anti-cleaved caspase-3 and antiphospho-Ser15 P53. Positive nuclear stain with the latter
antibody was observed in essentially all cells positive for cleaved caspase-3 (n= 180). Scale bar= 10 μm. All data shown in the figure are representative of three independent
infections. (d) Western blot analysis of cleaved caspase-3, normalized on histone H3. (e) IF analysis of γH2Ax foci in control and ZIKV-infected cells 24 h after infection. Cells with
multiple foci are magnified in the inset. Scale bar= 10 μm. (f) The average number of foci per nucleus was automatically quantified. ***Po0.001; **Po0.01 (two-tailed unpaired
Student's t-test)
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accumulation.32,52,54,55 The recent report that DNA damage
and consequent P53 activation can result from increased
mitosis length in neural progenitors32 suggests that this
mechanism could be much more common in microcephaly
than previously thought, because many microcephaly genes
have the potential to impact on mitosis timing.4,7 However,
P53-dependent apoptosis can also be produced through other
mechanisms responsible for microcephaly syndromes, such
as alteration of chromatin remodeling56 and block of miRNA
function.53,57 Our bioinformatic analysis further confirms and
extends this concept, showing that a transcriptional signature
of P53 activation characterizes not only the CitK and Magoh
models but also the microcephaly produced by Elp3 deletion.
The fact that in the latter case no apoptosis was detected26
is consistent with reports showing that UPR and ER
stress, which characterizes Elp3 microcephaly,26 may acti-
vate mechanisms capable of preventing P53-dependent
death.58,59 Nevertheless, P53 activation and transcriptional
induction of some P53 targets can still be sufficient to
induce the growth arrest detected in Elp3-deficient neural
progenitors.26
The high overlap between genes modulated by ZIKV
infections and P53-related data sets (Table 1) suggested that
ZIKV may strongly activate P53. Consistent with this predic-
tion, we showed that ZIKV-infected hNPGs display increased
P53 total levels, nuclear accumulation and Ser15 phosphor-
ylation, which are all markers of P53 activation.44–46 Moreover,
in ZIKV-infected cultures, most caspase-3-positive cells were
positive for phospho-Ser15 P53, suggesting that P53 activa-
tion is responsible for apoptosis induction. Notably, P53
nuclear accumulation and caspase-3 positivity were detected
not only in cells strongly positive for viral antigens but also
in cells producing very low to undetectable levels of viral
proteins (Figures 2 and 3). These results are consistent with
those previously obtained in human brain organoids15 and in
infected mouse brains,16 showing that apoptosis can be
induced by ZIKV in cells apparently negative for virus
expression. Altogether, they suggest that the cytopathic
effects produced by ZIKV in developing neural tissue are not
a simple consequence of cell stress deriving from viral burden,
but may be the consequence of specific mechanisms
leading to P53 activation. In support of this view, the response
elicited on P53-related genes by CMV is quite at the opposite,
with upregulation of proproliferative genes (Table 1 and
Supplementary Table S4). Flaviviruses are known to activate
P53 and to produce P53-dependent apoptosis.60,61 In the
case of West Nile Virus, it was shown that P53 activation may
be caused by nucleolar sequestration of Hdm2 by capsid core
protein.61 However, the P53 activation, which we detected in
cells expressing low or undetectable levels of viral antigens,
seems not compatiblewith thismechanism. A second possible
cause of P53 activation is genotoxic stress, which could be
produced by different mechanisms. For instance, ZIKV could
induce the production of reactive oxygen species (ROS), as it
has been shown in the case of hepatitis C virus (HCV).62
Moreover, decreased expression of DNA repair genes was
detected in ZIKV-infected cells.12 We found that ZIKV infection
increases DNA damage in cultured hNPCs (Figures 3d
and e). This phenotype is already visible in cells with low to
undetectable levels of viral antigens and become more
pronounced with the increase of viral load (Figures 3d and
e). Therefore, a likely possibility is that P53 activation by ZIKV
is a cell-autonomous consequence of genotoxic stress. This
scenario would imply that ZIKV can induce increased DNA
damage very early during replication cycle, as the phenotype
is already measurable when viral antigens are not yet clearly
detectable by IF.
An alternative possibility to explain our results could be that
DNA damage is not the cause, but rather a consequence of
P53 activation. For instance, it could be the result of increased
levels of P53-regulated nucleases, such as AEN. This
scenario would be compatible with non-cell-autonomous
mechanisms of P53 activation. In support of this view, it has
been reported that ZIKV induces TLR3 overexpression and
that TLR3 inhibition attenuates the effects of ZIKV on cell
growth.13 In addition, studies in non-neural cells have shown
that ZIKV induces interferon-β (IFN-β),63 which in turn may
activate P53 and many proapoptotic P53-target genes,
including TLR3.64–66 However, it must also be mentioned that
IFN-β can promote survival of neural precursors,67 rather than
killing them. In addition, it has been reported that ZIKV can
have inhibitory roles on type-I IFN signaling, through STAT2
targeting.68
More studies are certainly necessary to dissect the cause-
effect chain. However, as ZIKV can induce genotoxic stress,
activate P53 and promote cell death when viral proteins are
barely detectable (Figures 2 and 3), an outstanding question is
how could infected cells become tolerant to high levels of DNA
damage and high viral burden? To address this question, it
may be helpful to consider that the gene expression profile of
ZIKV-infected cells overlaps better with the Elp3 (character-
ized by ER stress but not apoptosis26) than with CitK and
Magoh models (which display high apoptosis levels; Di Cunto
et al.24 and Pilaz et al.32). As ER stress can protect cells from
P53-dependent apoptosis,58,59 it is possible that during the
early stages of the infection cycle ZIKV-induced genotoxic
stressmay lead to a P53-dependent proapoptotic response. In
the surviving cells, the accumulation of viral proteins could
lead to UPR and ER stress, leading not only to cell adaptation
and survival but also to cell-cycle arrest. A similar mechanism
has already been demonstrated in the case of HCV, whose
NS4B protein is capable not only of inducing a proapoptotic,
ROS-dependent response but also of promoting a protective
response mediated by the NF-κB transcription factor.62
Interestingly, an independent bioinformatic analysis of the
same data set considered in our study showed that NF-κB
pathway is activated in ZIKV-infected cells.69
In conclusion, although more investigations are required to
discriminate between these possibilities, our study highlights
P53 and a very limited number of P53-target genes as
possible crucial mediators of ZIKV-induced growth arrest and
apoptosis.
Materials and Methods
Comparison of expression profiles. RNA-seq data of ZIKV-infected
hNPCs and controls were obtained from GEO RNA-seq data set GSE78711.12 The
lists of differentially expressed genes (Supplementary Table S1) were defined as in
the original paper.12
RNA-seq-based gene expression data of CitK− /− mice and controls were
obtained from P4 developing cerebellum (Bianchi et al., unpublished, data set is being
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submitted to GEO). Differentially expressed genes were defined using Cuffdiff
v.2.0.2,70 with a 0.05 false discovery rate cutoff.
Microarray-based gene expression data of E10.5 Magoh-deficient mouse
cortices25 were obtained from GEO data set GSE19168. The lists of differentially
expressed genes (Supplementary Table S1) were defined as in the original paper.25
RNA-seq-based gene expression data of E13.5 Elp3− /− brains and controls26
were obtained from GEO data set GSE74683. The lists of differentially expressed
genes (Supplementary Table S1) were defined as in the original paper.26
Microarray-based gene expression data of CMV-infected hNPCs41 were obtained
from GEO data set GSE19345. Differentially expressed genes (Supplementary Table
S1) were defined as those showing statistically significant deviation from control in the
three time points of the time-course experiment, as defined the original paper.41
P-values of the intersections between the different lists were calculated using the
Fisher's exact test. For GSEA analysis,40 P53-related data sets were downloaded
from Molecular Signature Database (http://software.broadinstitute.org/gsea) and their
overlap with genes upregulated in the above-described data sets was determined.
P-values were then calculated using the Fisher's exact test, with Benjamini–Hochberg
correction for 50 tests.
Viral titration and infection. ZIKV strain PF13, isolated from French
Polynesia, was amplified on Vero-E6 cells, maintained in DMEM containing 10%
fetal calf serum (Sigma, St. Louis, MO, USA). For infection, virus was diluted in
serum-free DMEM at the multiplicity of infection 1 (MOI 1). Viral inoculum was
overlaid on cells for 30 min before medium replenishment. Supernatants were
collected at indicated times for plaque assay where appropriate. For titration,
dilutions of cell supernatant were prepared in serum-free DMEM and used to
inoculate confluent monolayers of Vero-E6 cells for 30 min to 1 h at 37 °C. Cells
were then overlaid with 0.8% agarose in DMEM containing 1.6% NBCS. ZIKV
samples were incubated for 4 days. Following incubation, cells were fixed with 4%
formalin and revealed with crystal violet solution (10% crystal violet (Sigma-Aldrich),
20% ethanol). Plaques were enumerated and used to back-calculate the number of
plaque-forming units per milliliter of collected volume.
Cell culture. Human i90c16 were derived from IMR-90 lung fibroblast cell
(ATCC; Manassas, VA, USA, CCL-186) as described previously,71 using Addgene
plasmid 20925, 20926 and 20927. Differentiation of i90c16 hiPSC into neural stem
cells (NSCi90) was performed as described previously.72,73
Cells were seeded on poly-ornithine/laminin- (Sigma) coated nitric acid-treated
glass coverslips. The cells were grown in 50% DMEM:F12/50% Neurobasal medium
(Invitrogen) supplemented with 1 × N2 (Invitrogen, Carlsbad, CA, USA), 1 × B27
(Invitrogen), 10 ng/ml FGF2 (Peprotech, Rocky Hill, NJ, USA) and EGF at 10 ng/ml
(R&D Systems, Minneapolis, MN, USA). The medium was changed every alternate
day and cells were passaged every 5 days. For infection with ZIKV, the medium was
removed and virus was inoculated at MOI 1 in serum-free medium for 30 min. Wells
were then replenished with fresh medium for 48 h.
Immunocytochemical analysis. Control and infected NSCi90 were fixed
for 20 min with 4% paraformaldehyde. Cells were permeabilized with 0.3% Triton
5 min X-100 for, washed, blocked for 1h with 10% serum in PBS and incubated with
primary antibody overnight at 4 °C. Primary antibodies used were anti-p53 (7F5)
(1:1600, no. 2527; Cell Signaling Technology, Boston, MA, USA), anti-D1-4G2-4-15
antibody (4G2) against flaviviruses (1:1500, MAB10216; Millipore, Darmstadt,
Germany), antiphospho-Ser15 P53 (16G8) (1:400, no. 9286; Cell Signaling
Technology), anti-activated caspase-3 (Asp175) (1:400, no. 9661; Cell Signaling
Technology) and γH2AX (S139, 20E3) (1:200, no. 9718; Cell Signaling Technology).
Following washing, cells were treated with secondary antibody (1:1000 dilution) for
1h in dark at room temperature. Immunofluorescent cells were analyzed using a
Leica TCS SP8 confocal scanning system (Leica Microsystems, Wetzlar, Germany)
equipped with 488 nm Ar and 561 nm DPSS lasers. Eight-bit digital images were
collected from a single optical plane using a × 40 HC PL APO CS2 oil-immersion
Leica objective. For each optical section, double- or triple-fluorescence images were
acquired in sequential mode to avoid potential contamination by linkage-specific
fluorescence emission cross-talk. Settings for laser intensity, beam expander,
pinhole (1 Airy unit), range property of emission window, electronic zoom, gain and
offset of photomultiplicator, field format and scanning speed were optimized initially
and held constant throughout the study so that all coverslips were digitized under
the same conditions. Quantitative identification of ZIKV-positive and -negative cells,
measurement of nuclear P53 signal intensity and quantification of the average
number of γH2AX foci were obtained using the Fiji Software.74 In particular, the
latter quantification was obtained using the command 'Find Maxima' after the
appropriate setting of the threshold and noise.
Western blotting. Whole-cell extracts were fractionated by SDS-PAGE and
transferred to a polyvinylidenedifluoride membrane. After incubation with either 10%
BSA (P53 blot) or 10% nonfat milk (Ser15 P53, cleaved caspase-3 and actin blots)
in TBST (10 mM Tris, pH 8.0, 150 mM NaCl, 0.5% Tween-20) for 1 h, membranes
were incubated in 5% BSA or nonfat milk with antibodies against P53 (7F5, no.
2527; Cell Signaling Technology; dilution 1:1000), Ser15-phospho-P53 (16G8,
no. 9286; Cell Signaling Technology; dilution 1:1000), cleaved caspase-3 (Asp175,
no. 9661; Cell Signaling Technology; dilution 1:1000) or β-actin (MAB1501;
Millipore; dilution 1:10000), histone H3 (1B1B2, no. 14269; Cell Signaling
Technology; dilution 1:1000) overnight at 4 °C. Membranes were washed three
times for 15 min and incubated for 1 h with horseradish peroxidase-conjugated
anti-mouse or anti-rabbit antibodies. Blots were again washed three times with
TBST and developed with the Western Lightning UltraRChemiluminescence
Substrate (Perkin-Elmer Inc., Waltham, MA, USA) according to the manufacturer's
protocols.
Quantification of gene expression by real-time qPCR. Total RNA
was extracted with the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. RNA quality and concentration were assessed by
spectrophotometry with a Nanodrop apparatus (Thermo Fisher Scientific, Waltham,
MA, USA). Total RNA (120 ng) was subjected to two independent reverse
transcriptions using the iScript cDNA Synthesis Kit (Bio-Rad). qPCR was performed
in duplicate on the 2 RT for each sample using SYBR Green Supermix (Bio-Rad) for
40 cycles with a two-step program (5 s of denaturation at 95 °C and 10 s of
annealing at 60 °C) on a CFX384 (Bio-Rad, Marnes-la-Coquette, France).
Amplification specificity was assessed with a melting-curve analysis. Primers were
designed using the Primer3 plus Software (http://primer3plus.com). Specific mRNA
levels were calculated after normalization of the results for each sample with those
for GAPDH mRNA (reference gene). The data are presented as relative mRNA
units with respect to control group (GOI/GAPDH expressed as fold over control
value). Analyses were performed with the Bio-Rad CFX Manager 3.0 Software
(http://primer3plus.com). Statistical analyses were performed using the
GraphPadPrism 5.0 software (GraphPad Software, Inc., La Jolla, CA, USA) and
results were compared using the Mann–Whitney U-test. A two-tailed Po0.05 was
considered significant.
Primers used (5'–3') were as follows: hCDKN1C-FAGCTGCACTCGGGGATTT
and hCDKN1C-RCTTCTCAGGCGCTGATCTCT; hEDA2R-FTGGATTGCCAAGAAA
ATGAG and hEDA2R-RGCATCTCCACCCTCTCCATA; hCCNG1-FTCCAAGCACA
GAAGTGTGTAGAG and hCCNG1-RTGGTTTGGAACACTTATTTGATG; hAEN-FCA
TCACTCGGCAGCACAT and hAEN-RCCTGGAAGTCGTTGTGCAG; hCDKN1A-
FGGAGACTCTCAGGGTCGAAA andhCDKN1A-RTAGGGCTTCCTCTTGGAGAA;
hPHLDA3-FCAGGCCATCCAGACAGTG and hPHLDA3-RCCCCCACAAGCCAGA
GG; hGAPDHAAAGGGTCATCATCTCTGCC and hGAPDHAGGGGTGCTAAGCA
GTTGGT.
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